Annotation Detail for MOBKL2B

Basic Information
Top
Gene Symbol: | MOBKL2B ( FLJ13204,FLJ23916,MGC32960,MOB3B ) |
---|
Gene Full Name: | MOB1, Mps One Binder kinase activator-like 2B (yeast) |
---|
Band: | 9p21.2 |
---|
Quick Links | Entrez ID:79817; OMIM: NA; Uniprot ID:MOL2B_HUMAN; ENSEMBL ID: ENSG00000120162; HGNC ID: |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
Desease Name |
---|
Amyotrophic Lateral Sclerosis |
NEUROLOGICAL |
Desease Name |
---|
Heart failure |
Amyotrophic lateral sclerosis |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MOBKL2B mRNA | decreases expression | 20064835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MOBKL2B mRNA | decreases expression | 19150397
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MOBKL2B mRNA | decreases expression | 20106945
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MOBKL2B mRNA | affects binding|decreases expression|increases activity | 19710929
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of MOBKL2B mRNA | increases expression | 18175754
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.05 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.84 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.02 | 16434500 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.56 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.52 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 17474063 20146248 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.13 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.35 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.35 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.63 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.63 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.24 | 15894690 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.10 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.36 | 15131321 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.85 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.59 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.59 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.82 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.82 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.62 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.82 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.48 | 16221962 19176532 19772884 18467677 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.20 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
8.04 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
8.04 | 14714311 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.52 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.04 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.73 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.73 | 20007298 15890375 16377806 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.57 | 17053015 18569708 20064080 20135361 18520028 18816296 20869020 20464547 6695378 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.46 | 14737004 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.46 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.33 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.33 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 19348381 18481113 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.15 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.15 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.51 | 10029692 19755658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.29 | 17053015 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |